Wynford Dore, Presenting New Neuroscientific Research in First-Ever Autism Conference Appearance, to Share Stage with Dr. Albert Mensah

Veteran innovator and educator Wynford Dore and physician Albert Mensah, MD, to speak at AutismOne 2020 Conference in Chicago, May 23rd.

AutismOne today announced the complementary presentations of Dr. Albert Mensah and Wynford Dore on May 23, 2020.

Following a family member’s despair due to learning struggles, innovator Wynford Dore of the UK partnered with researchers to discover and implement life-changing methods for individuals to learn and flourish, thus improving their quality of life. Dore’s work stemmed from research from Harvard Medical School indicating that the cerebellum has a far more important role than previously thought. The cerebellum doesn’t just control motor and balance coordination — it is involved with a wide range of cognitive, memory, and emotional control functions. Dore’s Zing Performance, an individualized exercise program whereby brain plasticity is increased, has yielded rapid progress in learning and skill development. Dore teams with a world-class expert panel. He is a board member of The REACH Institute in New York, which is a charity dedicated to supporting families with children with learning issues.

Wynford Dore will present at the AutismOne 2020 Conference on Saturday, May 23rd on “Brain Plasticity, Neuroscience, and Overcoming Limitations to Unlock Hidden Potential.”

Albert H. Mensah, MD, is the co-founder of Mensah Medical in Warrenville, IL, a clinic that specializes in the treatment of biochemical imbalances and the cognitive (and physical) disorders caused by those imbalances. As a physician in this specialized field since 2005, Dr. Mensah has treated over 30,000 patients using all-natural, non-pharmaceutical, targeted nutrient therapy. His practice focuses on the management and treatment of cognitive disorders such as autism spectrum disorder, behavior/learning disorders, eating disorders, bipolar disorder, anxiety syndromes, childhood and adult schizophrenia, Alzheimer’s disease, Parkinson’s disease, and family medicine. More recently, Dr. Mensah co-founded the Mensah Research Institute, a not-for-profit organization dedicated to conducting, supporting, and presenting research that provides scientific evidence of the efficacy of targeted nutrient therapy and other natural approaches to improving brain function and to enhancing and optimizing mind/body health and balance.

Dr. Mensah will speak at the AutismOne 2020 Conference on Saturday, May 23rd on “What We Know Now: Treating the Root Causes of Autism and Other Learning, Behavioral, and Neurological Conditions.”

Said DJ Wells of Mensah Medical: “Mensah Medical collaborates with Wynford Dore in the use of Zing Performance.” DJ emphasized that Zing is an excellent complement to biomedical remediation offered at Mensah Medical: “We’re seeing good results with individuals who use Zing Performance in our clinic. You need to get your chemistry straight so you can be most effective once you get started with the Zing Performance program.”

The AutismOne 2020 Conference will be held at the beautiful Loews Chicago O’Hare Hotel, which is just ten minutes from Chicago O’Hare International Airport, May 20-24. For more information or to register, please visit http://www.autismoneconference.com.


Wynford Dore

…the cerebellum has a far more important role than previously thought